Rebekah J. Nevel

Jun 1, 2024 | onlinelibrary.wiley.com | Daniel Hinds |Rebekah J. Nevel |Deborah R. Liptzin |Andrew Barber

1 CHILD An important aspect of children's interstitial lung disease (chILD) is clear and concise classification of the diseases that enhance provider education and diagnostic abilities. Nathan et al.1 describe the European approach to diagnosing chILD, including descriptions of the most likely disease based on clinical histories, histopathology findings, radiographic findings, bronchoalveolar lavage results, genetic testing, and other “biological investigations” (i.e., lab testing).

Jul 4, 2023 | onlinelibrary.wiley.com | Rebekah J. Nevel |Gail Deutsch |Daniel Craven |Pediatric Pulmonology

CONFLICTS OF INTEREST STATEMENT R. D.: Now Vitals (CEO and Founder), Boehringer Ingelheim (Consultant and Coordinating Investigator), Earables (Founder and Chief Medical Officer), EvoEndo (Consultant and Founder) Roche, Inc. (Consultant), The France Foundation (Consultant). J. A. W.: received fees from Simumetrix for continuing medical education (CME) for childhood interstitial lung disease. J. T. W.: prior consultant for Merck Pharmaceuticals. E. K.